Full Text View
Tabular View
No Study Results Posted
Related Studies
Dalteparin's Influence on Renally Compromised: Anti-Ten-A Study (DIRECT)
This study has been completed.
Study NCT00138099   Information provided by McMaster University
First Received: August 29, 2005   Last Updated: May 30, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Renal Insufficiency
More general conditions related to this trial
Kidney Diseases
Urologic Diseases
Interventions listed in this trial
Fragmin (dalteparin sodium)
Additional drug interventions recognized in this trial
Dalteparin
More general drug interventions related to this trial
Anticoagulants
Cardiovascular Agents
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Hamilton Health Sciences
Canadian Critical Care Trials Group
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services